Side-by-side comparison of AI visibility scores, market position, and capabilities
AI phone platform for dental practices handling patient scheduling, insurance verification, and reactivation campaigns; $3.8M seed from YC serving DSOs competing with Weave and NexHealth.
Newton is an AI-powered phone and patient communication platform for dental practices and dental service organizations (DSOs) — deploying AI voice agents that handle inbound patient calls (appointment scheduling, insurance verification questions, appointment reminders) and outbound patient reactivation campaigns that identify and contact overdue patients, automating the front-desk phone work that consumes significant staff time at dental offices. Founded in 2023 in San Francisco and a Y Combinator W24 graduate, Newton raised $3.8 million in seed funding in October 2025 from Y Combinator, Twenty Two Ventures, Transpose Platform, and Phosphor Capital.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.